Combined High-Density Lipoprotein Proteomic and Glycomic Profiles in Patients at Risk for Coronary Artery Disease

Journal of Proteome Research

Volumn 14, Issue 12, 2015, Pages 5109-5118

  Krishnan, Sridevi ^a   Huang, Jincui ^a   Lee, Hyeyoung ^a   Guerrero, Andres ^a   Berglund, Lars ^b,c   Anuurad, Erdembileg ^b   Lebrilla, Carlito B ^a   Zivkovic, Angela M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

apolipoproteins; atherosclerosis; cardiovascular disease; coronary artery disease; glycolipids; glycomics; HDL; proteomics

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN E; CARBOHYDRATE; GANGLIOSIDE; GLYCAN; HIGH DENSITY LIPOPROTEIN; PROTEOME; SERUM AMYLOID A; SERUM AMYLOID A2; SERUM AMYLOID A4; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATHEROSCLEROSIS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; FEMALE; GLYCOBIOLOGY; HIGH RISK PATIENT; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MIDDLE AGED; PRIORITY JOURNAL; PROTEOMICS; ULTRACENTRIFUGATION; AGED; BLOOD; CHEMISTRY; CORONARY ANGIOGRAPHY; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES; RANDOMIZATION; RISK FACTOR;

ADULT; AGED; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; GANGLIOSIDES; GLYCOMICS; HUMANS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; PROTEOMICS; RANDOM ALLOCATION; RISK FACTORS;

EID: 84949009931     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/acs.jproteome.5b00730     Document Type: Article

References (70)

1. CDC National Center for Chronic Disease Prevention and Health Promotion, Division for Heart Disease and Stroke Prevention. http://www.cdc.gov/heartdisease/facts.htm.
2. Schwartz, G. G.; Olsson, A. G.; Abt, M.; Ballantyne, C. M.; Barter, P. J.; Brumm, J.; Chaitman, B. R.; Holme, I. M.; Kallend, D.; Leiter, L. A.; Leitersdorf, E.; McMurray, J. J.; Mundl, H.; Nicholls, S. J.; Shah, P. K.; Tardif, J. C.; Wright, R. S.; dal, O. I. Effects of dalcetrapib in patients with a recent acute coronary syndrome N. Engl. J. Med. 2012, 367 (22) 2089-99 10.1056/NEJMoa1206797
3. The AIM-HIGH Investigators; Boden, W. E.; Probstfield, J. L.; Anderson, T.; Chaitman, B. R.; Desvignes-Nickens, P.; Koprowicz, K.; McBride, R.; Teo, K.; Weintraub, W. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy N. Engl. J. Med. 2011, 365 (24) 2255-67 10.1056/NEJMoa1107579
4. Asztalos, B. F.; Tani, M.; Schaefer, E. J. Metabolic and functional relevance of HDL subspecies Curr. Opin. Lipidol. 2011, 22 (3) 176-85 10.1097/MOL.0b013e3283468061
5. Ansell, B. J.; Fonarow, G. C.; Fogelman, A. M. The paradox of dysfunctional high-density lipoprotein Curr. Opin. Lipidol. 2007, 18 (4) 427-34 10.1097/MOL.0b013e3282364a17
6. Vaisar, T.; Mayer, P.; Nilsson, E.; Zhao, X. Q.; Knopp, R.; Prazen, B. J. HDL in humans with cardiovascular disease exhibits a proteomic signature Clin. Chim. Acta 2010, 411 (13-14) 972-9 10.1016/j.cca.2010.03.023
7. Park, K. H.; Shin, D. G.; Kim, J. R.; Hong, J. H.; Cho, K. H. The functional and compositional properties of lipoproteins are altered in patients with metabolic syndrome with increased cholesteryl ester transfer protein activity Int. J. Mol. Med. 2010, 25 (1) 129-36
8. Riwanto, M.; Rohrer, L.; Roschitzki, B.; Besler, C.; Mocharla, P.; Mueller, M.; Perisa, D.; Heinrich, K.; Altwegg, L.; von Eckardstein, A.; Luscher, T. F.; Landmesser, U. Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling Circulation 2013, 127 (8) 891-904 10.1161/CIRCULATIONAHA.112.108753
9. Alwaili, K.; Bailey, D.; Awan, Z.; Bailey, S. D.; Ruel, I.; Hafiane, A.; Krimbou, L.; Laboissiere, S.; Genest, J. The HDL proteome in acute coronary syndromes shifts to an inflammatory profile Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 2012, 1821 (3) 405-15 10.1016/j.bbalip.2011.07.013
10. Maverakis, E.; Kim, K.; Shimoda, M.; Gershwin, M. E.; Patel, F.; Wilken, R.; Raychaudhuri, S.; Ruhaak, L. R.; Lebrilla, C. B. Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review J. Autoimmun. 2015, 57, 1-13 10.1016/j.jaut.2014.12.002
11. Moremen, K. W.; Tiemeyer, M.; Nairn, A. V. Vertebrate protein glycosylation: diversity, synthesis and function Nat. Rev. Mol. Cell Biol. 2012, 13 (7) 448-62 10.1038/nrm3383
12. Walsh, G.; Jefferis, R. Post-translational modifications in the context of therapeutic proteins Nat. Biotechnol. 2006, 24 (10) 1241-1252 10.1038/nbt1252
13. Sugano, M.; Yamauchi, K.; Kawasaki, K.; Tozuka, M.; Fujita, K.; Okumura, N.; Ota, H. Sialic acid moiety of apolipoprotein E3 at Thr(194) affects its interaction with beta-amyloid(1-42) peptides Clin. Chim. Acta 2008, 388 (1-2) 123-9 10.1016/j.cca.2007.10.024
14. Remaley, A. T.; Wong, A. W.; Schumacher, U. K.; Meng, M. S.; Brewer, H. B., Jr.; Hoeg, J. M. O-linked glycosylation modifies the association of apolipoprotein A-II to high density lipoproteins J. Biol. Chem. 1993, 268 (9) 6785-90
15. Fazio, S.; Horie, Y.; Weisgraber, K. H.; Havekes, L. M.; Rall, S. C., Jr. Preferential association of apolipoprotein E Leiden with very low density lipoproteins of human plasma J. Lipid Res. 1993, 34 (3) 447-53
16. Ueda, K.; Fukase, Y.; Katagiri, T.; Ishikawa, N.; Irie, S.; Sato, T. A.; Ito, H.; Nakayama, H.; Miyagi, Y.; Tsuchiya, E.; Kohno, N.; Shiwa, M.; Nakamura, Y.; Daigo, Y. Targeted serum glycoproteomics for the discovery of lung cancer-associated glycosylation disorders using lectin-coupled ProteinChip arrays Proteomics 2009, 9 (8) 2182-92 10.1002/pmic.200800374
17. Huang, J.; Lee, H.; Zivkovic, A. M.; Smilowitz, J. T.; Rivera, N.; German, J. B.; Lebrilla, C. B. Glycomic Analysis of High Density Lipoprotein Shows a Highly Sialylated Particle J. Proteome Res. 2014, 13 (2) 681-691 10.1021/pr4012393
18. Savinova, O. V.; Fillaus, K.; Jing, L.; Harris, W. S.; Shearer, G. C. Reduced apolipoprotein glycosylation in patients with the metabolic syndrome PLoS One 2014, 9 (8) e104833 10.1371/journal.pone.0104833
19. Anuurad, E.; Ozturk, Z.; Enkhmaa, B.; Pearson, T. A.; Berglund, L. Association of lipoprotein-associated phospholipase A2 with coronary artery disease in African-Americans and Caucasians J. Clin. Endocrinol. Metab. 2010, 95 (5) 2376-83 10.1210/jc.2009-2498
20. Anuurad, E.; Enkhmaa, B.; Gungor, Z.; Zhang, W.; Tracy, R. P.; Pearson, T. A.; Kim, K.; Berglund, L. Age as a modulator of inflammatory cardiovascular risk factors Arterioscler., Thromb., Vasc. Biol. 2011, 31 (9) 2151-6 10.1161/ATVBAHA.111.232348
21. Brousseau, T.; Clavey, V.; Bard, J. M.; Fruchart, J. C. Sequential ultracentrifugation micromethod for separation of serum lipoproteins and assays of lipids, apolipoproteins, and lipoprotein particles Clin. Chem. 1993, 39 (6) 960-4
22. Old, W. M.; Meyer-Arendt, K.; Aveline-Wolf, L.; Pierce, K. G.; Mendoza, A.; Sevinsky, J. R.; Resing, K. A.; Ahn, N. G. Comparison of label-free methods for quantifying human proteins by shotgun proteomics Mol. Cell. Proteomics 2005, 4 (10) 1487-1502 10.1074/mcp.M500084-MCP200
23. Wang, W.; Zhou, H.; Lin, H.; Roy, S.; Shaler, T. A.; Hill, L. R.; Norton, S.; Kumar, P.; Anderle, M.; Becker, C. H. Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards Anal. Chem. 2003, 75 (18) 4818-4826 10.1021/ac026468x
24. Ong, S.-E.; Mann, M. Mass spectrometry-based proteomics turns quantitative Nat. Chem. Biol. 2005, 1 (5) 252-262 10.1038/nchembio736
25. Chelius, D.; Bondarenko, P. V. Quantitative profiling of proteins in complex mixtures using liquid chromatography and mass spectrometry J. Proteome Res. 2002, 1 (4) 317-323 10.1021/pr025517j
26. Huang, J.; Lee, H.; Zivkovic, A. M.; Smilowitz, J. T.; Rivera, N.; German, J. B.; Lebrilla, C. B. Glycomic Analysis of High Density Lipoprotein Shows a Highly Sialylated Particle J. Proteome Res. 2014, 13, 681 10.1021/pr4012393
27. Hua, S.; An, H. J.; Ozcan, S.; Ro, G. S.; Soares, S.; DeVere-White, R.; Lebrilla, C. B. Comprehensive native glycan profiling with isomer separation and quantitation for the discovery of cancer biomarkers Analyst 2011, 136 (18) 3663-3671 10.1039/c1an15093f
28. Hua, S.; Williams, C. C.; Dimapasoc, L. M.; Ro, G. S.; Ozcan, S.; Miyamoto, S.; Lebrilla, C. B.; An, H. J.; Leiserowitz, G. S. Isomer-specific chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer Journal of Chromatography A 2013, 1279, 58-67 10.1016/j.chroma.2012.12.079
29. An, H. J.; Kronewitter, S. R.; de Leoz, M. L. A.; Lebrilla, C. B. Glycomics and disease markers Curr. Opin. Chem. Biol. 2009, 13 (5) 601-607 10.1016/j.cbpa.2009.08.015
30. Sansone, S. A.; Fan, T.; Goodacre, R.; Griffin, J. L.; Hardy, N. W.; Kaddurah-Daouk, R.; Kristal, B. S.; Lindon, J.; Mendes, P.; Morrison, N.; Nikolau, B.; Robertson, D.; Sumner, L. W.; Taylor, C.; van der Werf, M.; van Ommen, B.; Fiehn, O.; MSI Board Members The metabolomics standards initiative Nat. Biotechnol. 2007, 25 (8) 846-8 10.1038/nbt0807-846b
31. R Development Core Team. R: A language and environment for statistical computing; R Foundation for Statistical Computing: Vienna, Austria, 2008.
32. Gayoso-Diz, P.; Otero-Gonzalez, A.; Rodriguez-Alvarez, M. X.; Gude, F.; Garcia, F.; De Francisco, A.; Quintela, A. G. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study BMC Endocr. Disord. 2013, 13, 47 10.1186/1472-6823-13-47
33. Sung, K. C.; Ryu, S.; Wild, S. H.; Byrne, C. D. An increased high-density lipoprotein cholesterol/apolipoprotein A-I ratio is associated with increased cardiovascular and all-cause mortality Heart 2015, 101, 553 10.1136/heartjnl-2014-306784
34. Heinecke, J. W. The HDL proteome: a marker - and perhaps mediator - of coronary artery disease J. Lipid Res. 2009, 50 (Suppl) S167-71 10.1194/jlr.R800097-JLR200
35. Shah, A. S.; Tan, L.; Long, J. L.; Davidson, W. S. Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond J. Lipid Res. 2013, 54 (10) 2575-85 10.1194/jlr.R035725
36. Vaisar, T. Proteomics investigations of HDL: challenges and promise Curr. Vasc. Pharmacol. 2012, 10 (4) 410-21 10.2174/157016112800812755
37. Cabana, V. G.; Feng, N.; Reardon, C. A.; Lukens, J.; Webb, N. R.; de Beer, F. C.; Getz, G. S. Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro J. Lipid Res. 2004, 45 (2) 317-25 10.1194/jlr.M300414-JLR200
38. Voudris, K. V.; Chanin, J.; Feldman, D. N.; Charitakis, K. Novel Inflammatory Biomarkers in Coronary Artery Disease: Potential Therapeutic Approaches Curr. Med. Chem. 2015, 22, 2680 10.2174/0929867322666150420124427
39. Urieli-Shoval, S.; Linke, R. P.; Matzner, Y. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states Curr. Opin. Hematol. 2000, 7 (1) 64-9 10.1097/00062752-200001000-00012
40. Thompson, P. A.; Kitchens, R. L. Native high-density lipoprotein augments monocyte responses to lipopolysaccharide (LPS) by suppressing the inhibitory activity of LPS-binding protein J. Immunol. 2006, 177 (7) 4880-7 10.4049/jimmunol.177.7.4880
41. Song, C.; Hsu, K.; Yamen, E.; Yan, W.; Fock, J.; Witting, P. K.; Geczy, C. L.; Freedman, S. B. Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes Atherosclerosis 2009, 207 (2) 374-83 10.1016/j.atherosclerosis.2009.05.007
42. Banka, C. L.; Yuan, T.; de Beer, M. C.; Kindy, M.; Curtiss, L. K.; de Beer, F. C. Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux J. Lipid Res. 1995, 36 (5) 1058-65
43. Artl, A.; Marsche, G.; Lestavel, S.; Sattler, W.; Malle, E. Role of serum amyloid A during metabolism of acute-phase HDL by macrophages Arterioscler., Thromb., Vasc. Biol. 2000, 20 (3) 763-72 10.1161/01.ATV.20.3.763
44. Song, C.; Shen, Y.; Yamen, E.; Hsu, K.; Yan, W.; Witting, P. K.; Geczy, C. L.; Freedman, S. B. Serum amyloid A may potentiate prothrombotic and proinflammatory events in acute coronary syndromes Atherosclerosis 2009, 202 (2) 596-604 10.1016/j.atherosclerosis.2008.04.049
45. Johnson, B. D.; Kip, K. E.; Marroquin, O. C.; Ridker, P. M.; Kelsey, S. F.; Shaw, L. J.; Pepine, C. J.; Sharaf, B.; Bairey Merz, C. N.; Sopko, G.; Olson, M. B.; Reis, S. E.; National Heart, L.; Blood, I. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Circulation 2004, 109 (6) 726-32
46. Pearson, T. A.; Mensah, G. A.; Alexander, R. W.; Anderson, J. L.; Cannon, R. O., 3rd; Criqui, M.; Fadl, Y. Y.; Fortmann, S. P.; Hong, Y.; Myers, G. L.; Rifai, N.; Smith, S. C., Jr.; Taubert, K.; Tracy, R. P.; Vinicor, F. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 2003, 107 (3) 499-511 10.1161/01.CIR.0000052939.59093.45
47. Myers, G. L.; Rifai, N.; Tracy, R. P.; Roberts, W. L.; Alexander, R. W.; Biasucci, L. M.; Catravas, J. D.; Cole, T. G.; Cooper, G. R.; Khan, B. V.; Kimberly, M. M.; Stein, E. A.; Taubert, K. A.; Warnick, G. R.; Waymack, P. P. Cdc; Aha, CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group Circulation 2004, 110 (25) e545-9 10.1161/01.CIR.0000148980.87579.5E
48. King, V. L.; Thompson, J.; Tannock, L. R. Serum amyloid A in atherosclerosis Curr. Opin. Lipidol. 2011, 22 (4) 302-7 10.1097/MOL.0b013e3283488c39
49. Chiba, T.; Han, C. Y.; Vaisar, T.; Shimokado, K.; Kargi, A.; Chen, M. H.; Wang, S.; McDonald, T. O.; O'Brien, K. D.; Heinecke, J. W.; Chait, A. Serum amyloid A3 does not contribute to circulating SAA levels J. Lipid Res. 2009, 50 (7) 1353-62 10.1194/jlr.M900089-JLR200
50. Sellar, G. C.; Jordan, S. A.; Bickmore, W. A.; Fantes, J. A.; van Heyningen, V.; Whitehead, A. S. The human serum amyloid A protein (SAA) superfamily gene cluster: mapping to chromosome 11p15.1 by physical and genetic linkage analysis Genomics 1994, 19 (2) 221-7 10.1006/geno.1994.1051
51. Ely, S.; Bonatesta, R.; Ancsin, J. B.; Kindy, M.; Kisilevsky, R. The in-vitro influence of serum amyloid A isoforms on enzymes that regulate the balance between esterified and un-esterified cholesterol Amyloid 2001, 8 (3) 169-81 10.3109/13506120109007360
52. Badolato, R.; Wang, J. M.; Murphy, W. J.; Lloyd, A. R.; Michiel, D. F.; Bausserman, L. L.; Kelvin, D. J.; Oppenheim, J. J. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes J. Exp. Med. 1994, 180 (1) 203-9 10.1084/jem.180.1.203
53. Poitou, C.; Viguerie, N.; Cancello, R.; De Matteis, R.; Cinti, S.; Stich, V.; Coussieu, C.; Gauthier, E.; Courtine, M.; Zucker, J. D.; Barsh, G. S.; Saris, W.; Bruneval, P.; Basdevant, A.; Langin, D.; Clement, K. Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition Diabetologia 2005, 48 (3) 519-28 10.1007/s00125-004-1654-6
54. Afzali, B.; Bakri, R. S.; Bharma-Ariza, P.; Lumb, P. J.; Dalton, N.; Turner, N. C.; Wierzbicki, A. S.; Crook, M. A.; Goldsmith, D. J. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients J. Nephrol 2003, 16 (4) 540-5
55. Gopaul, K. P.; Crook, M. A. Sialic acid: a novel marker of cardiovascular disease? Clin. Biochem. 2006, 39 (7) 667-81 10.1016/j.clinbiochem.2006.02.010
56. Crook, M. A.; Earle, K.; Morocutti, A.; Yip, J.; Viberti, G.; Pickup, J. C. Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria Diabetes Care 1994, 17 (4) 305-10 10.2337/diacare.17.4.305
57. Orekhov, A. N.; Tertov, V. V.; Mukhin, D. N.; Mikhailenko, I. A. Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients Biochem. Biophys. Res. Commun. 1989, 162 (1) 206-11 10.1016/0006-291X(89)91982-7
58. Tertov, V. V.; Sobenin, I. A.; Gabbasov, Z. A.; Popov, E. G.; Orekhov, A. N. Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins Biochem. Biophys. Res. Commun. 1989, 163 (1) 489-94 10.1016/0006-291X(89)92163-3
59. Sobenin, I. A.; Tertov, V. V.; Orekhov, A. N.; Smirnov, V. N. Synergetic effect of desialylated and glycated low density lipoproteins on cholesterol accumulation in cultured smooth muscle intimal cells Atherosclerosis 1991, 89 (2-3) 151-4 10.1016/0021-9150(91)90055-8
60. Tertov, V. V.; Sobenin, I. A.; Gabbasov, Z. A.; Popov, E. G.; Jaakkola, O.; Solakivi, T.; Nikkari, T.; Smirnov, V. N.; Orekhov, A. N. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization Lab Invest 1992, 67 (5) 665-75
61. Sobenin, I. A.; Tertov, V. V.; Koschinsky, T.; Bunting, C. E.; Slavina, E. S.; Dedov, II; Orekhov, A. N. Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells Atherosclerosis 1993, 100 (1) 41-54 10.1016/0021-9150(93)90066-4
62. Tertov, V. V.; Kaplun, V. V.; Sobenin, I. A.; Orekhov, A. N. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification Atherosclerosis 1998, 138 (1) 183-95 10.1016/S0021-9150(98)00023-9
63. Filipovic, I.; Schwarzmann, G.; Mraz, W.; Wiegandt, H.; Buddecke, E. Sialic-acid content of low-density lipoproteins controls their binding and uptake by cultured cells Eur. J. Biochem. 1979, 93 (1) 51-5 10.1111/j.1432-1033.1979.tb12793.x
64. Tertov, V. V.; Orekhov, A. N.; Sobenin, I. A.; Morrisett, J. D.; Gotto, A. M., Jr.; Guevara, J. G., Jr. Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease Journal of lipid research 1993, 34 (3) 365-75
65. Sobenin, I. A.; Tertov, V. V.; Orekhov, A. N. Characterization of chemical composition of native and modified low density lipoprotein occurring in the blood of diabetic patients Int. Angiol 1994, 13 (1) 78-83
66. Tertov, V. V.; Bittolo-Bon, G.; Sobenin, I. A.; Cazzolato, G.; Orekhov, A. N.; Avogaro, P. Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions Exp. Mol. Pathol. 1995, 62 (3) 166-72 10.1006/exmp.1995.1018
67. Tertov, V. V.; Sobenin, I. A.; Orekhov, A. N. Similarity between naturally occurring modified desialylated, electronegative and aortic low density lipoprotein Free Radical Res. 1996, 25 (4) 313-9 10.3109/10715769609149054
68. Garner, B.; Harvey, D. J.; Royle, L.; Frischmann, M.; Nigon, F.; Chapman, M. J.; Rudd, P. M. Characterization of human apolipoprotein B100 oligosaccharides in LDL subfractions derived from normal and hyperlipidemic plasma: deficiency of alpha-N-acetylneuraminyllactosyl-ceramide in light and small dense LDL particles Glycobiology 2001, 11 (10) 791-802 10.1093/glycob/11.10.791
69. Prokazova, N. V.; Orekhov, A. N.; Mukhin, D. N.; Mikhailenko, I. A.; Kogtev, L. S.; Sadovskaya, V. L.; Golovanova, N. K.; Bergelson, L. D. The gangliosides of adult human aorta: intima, media and plaque Eur. J. Biochem. 1987, 167 (2) 349-52 10.1111/j.1432-1033.1987.tb13343.x
70. Mukhin, D. N.; Prokazova, N. V.; Bergelson, L. D.; Orekhov, A. N. Ganglioside content and composition of cells from normal and atherosclerotic human aorta Atherosclerosis 1989, 78 (1) 39-45 10.1016/0021-9150(89)90157-3